Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A first in disease phase 2, randomised, controlled trial of Granulocyte-Macrophage Colony-Stimulating factor neutralisation for Axial Spondyloarthritis (NAMASTE study)

BOWNESS P., (2024), Lancet Rheumatology

Elevated type-17 cytokines are present in Axial Spondyloarthritis stool

BOWNESS P. and BROUGH I., (2024), Discovery Immunology

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Barnkob MB. et al, (2024), Nat Commun, 15

Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?

McMaster B. et al, (2024), Nat Methods

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.

Drury RE. et al, (2024), Nat Commun, 15

Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.

Ali M. et al, (2024), Clin Exp Immunol

Type I interferon regulation by USP18 is a key vulnerability in cancer

Jové V. et al, (2024), iScience, 27

Role of the Lymphatics in Cardiac Disease.

Cooper STE. et al, (2024), Arterioscler Thromb Vasc Biol

Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease.

Luke JJ. et al, (2024), J Immunother Cancer, 12

Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.

Wyatt NJ. et al, (2024), BMJ Open, 14

Evaluation of the accuracy of bacterial genome reconstruction with Oxford Nanopore R10.4.1 long-read-only sequencing

SANDERSON N. et al, (2024), Microbial Genomics

Development and Implementation of a Core Genome Multilocus Sequence Typing (cgMLST) scheme forHaemophilusinfluenzae

Krisna MA. et al, (2024)

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nat Commun, 15

No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia

Wei J. et al, (2024), Journal of Infection

A cross-disease, pleiotropy-driven approach for therapeutic target prioritization and evaluation.

Bao C. et al, (2024), Cell Rep Methods

Smoothing in linear multicompartment biological processes subject to stochastic input

Browning A. et al, (2024), Physical Review E: Statistical, Nonlinear, and Soft Matter Physics

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Barnkob MB. et al, (2024), Nat Commun, 15

Mitochondrial control of lymphocyte homeostasis.

Yazicioglu YF. et al, (2024), Semin Cell Dev Biol, 161-162, 42 - 53

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181

Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in the Laos

Chansamouth V. et al, (2024), Wellcome Open Research, 9, 183 - 183

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?